Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.
Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer. Clin Cancer Res. 2013 Nov 15; 19(22):6163-72.
View in:
PubMed
subject areas
Animals
Anti-Inflammatory Agents
Antineoplastic Agents, Phytogenic
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Caspase 3
Cell Line, Tumor
Dexamethasone
Drug Resistance, Neoplasm
Dual Specificity Phosphatase 1
Female
Gene Expression
Hormone Antagonists
Humans
Immediate-Early Proteins
Mice
Mice, SCID
Mifepristone
Neoplasm Recurrence, Local
Neoplasm Transplantation
Paclitaxel
Poly(ADP-ribose) Polymerases
Receptors, Estrogen
Receptors, Glucocorticoid
Signal Transduction
Transplantation, Heterologous
Triple Negative Breast Neoplasms
authors with profiles
Ben Hall
Suzanne D. Conzen